Tags:BioTechMedtechProduct
Velicept is a biotechnology company developing pharmaceutical products for the treatment of overactive bladder and irritable bowel syndrome.
Investors 2
Funding Rounds 2
Mentions in press and media 9
| Date | Title | Description | Source |
| 17.10.2018 | Term Sheet — Wednesday, October 17 | THREE THINGS
Good morning, Term Sheet readers.
Paid Content What you need to know about growing cy... | fortune.co... |
| 16.10.2018 | Velicept Therapeutics Raises an Additional $15 Million in Se... | MALVERN, Pa.--(BUSINESS WIRE)--Velicept Therapeutics, a privately-held clinical stage pharmaceutical... | citybizlis... |
| 16.10.2018 | Velicept Therapeutics Inks $15M Series B |
MALVERN, PA, Velicept Therapeutics, a clinical stage pharmaceutical company focused on treating ur... | vcnewsdail... |
| 16.10.2018 | Velicept Therapeutics Raises Additional $15M | Velicept Therapeutics, a Malvern, PA-based clinical stage pharmaceutical company focused on advancin... | finsmes.co... |
| 16.10.2018 | Velicept Therapeutics Raises an Additional $15M In Series B | MALVERN, Pa.--(BUSINESS WIRE)--Velicept Therapeutics, a privately-held clinical stage pharmaceutical... | citybizlis... |
| 03.12.2015 | Velicept nets $21M for overactive bladder drug | Solabegron works by relaxing the bladder smooth muscle by stimulating beta 3-adenoreceptors. Previou... | medcitynew... |
| 02.12.2015 | Daily funding roundup - December 2, 2015 | ORIC Pharmaceuticals bagged $53M; Bluecore raised $21M; Osaro announced $3.3M funding
Technology in... | vator.tv/n... |
| 01.12.2015 | Velicept Therapeutics Closes First Tranche of $21M Series B ... | Velicept Therapeutics, Inc., a Malvern, PA-based clinical development company, closed on the first t... | finsmes.co... |
| - | Velicept nets $21M for overactive bladder drug | Pennsylvania startup Velicept Therapeutics has closed out the first tranche of a $21 million Series ... | medcitynew... |
